Antimicrobial Resistance urges NHS to test “subscription-like” payment model for treatments

UK Government recently announced details for how they plan to support pharmaceutical companies’ investments in the development of drugs to treat antibiotic resistant infections. The NHS looks to test a first-of-its-kind ‘subscription-style’ payment model that will help incentivise companies to develop new drugs required for tackling antibiotic resistant infections. The plan arose after the launch

Continue Reading

New findings highlight drugs that pose Dementia risk

Findings reported in JAMA Internal Medicine Journal have found medicines, which belong to a family of drugs called anticholinergics, have already been linked to short-term problems with thinking. Now a large study of UK patients raises concerns about possible long-term brain side effects. Experts stress the findings do not prove there is a direct risk

Continue Reading

British Medical Journal publishes new guideline for subclinical hypothyroidism

BMJ has released a new clinical practice guideline for evaluating benefits and harms of thyroid hormones for adults with subclinical hypothyroidism (SCH), triggered by a recent systematic review of randomised controlled trials, which could lead to a change in current procedure. The guideline states that thyroid hormones should not be routinely offered to adults with SCH

Continue Reading